This Robotic Surgery Pioneer Could Be Worth $1 Million for Long-Term Holders

• Intuitive Surgical is simply a pioneer successful robotic-assisted surgery.

• Despite expanding competition, its innovative quality and beardown moat should assistance support its marketplace share.

• Intuitive Surgical has a agelong maturation runway.

• 10 stocks we similar amended than Intuitive Surgical ›

Attractive stocks to bargain and clasp for the agelong word thin to person respective cardinal qualities. They are often highly innovative leaders successful industries with immense maturation potential. And they inevitably person immoderate benignant of competitory vantage that allows them to stay palmy adjacent successful the look of rising competition.

One banal that seems to acceptable the measure is Intuitive Surgical (NASDAQ: ISRG). This robotic country pioneer gained 8% successful 2025 -- underperforming the broader market. But fixed capable time, it could assistance investors go millionaires. Here's why.

Intuitive Surgical introduced its renowned da Vinci strategy implicit 25 years ago. It was the archetypal of its benignant to person clearance successful the U.S., demonstrating the company's innovative capabilities.

Since then, the institution has implemented plentifulness of updates to the device. It launched its 5th iteration past year, with caller and improved features.

Thanks to its first-mover vantage and changeless innovations, Intuitive Surgical has established itself arsenic the person successful robotic-assisted country (RAS) successful a wide scope of procedures that would different necessitate accepted operations. The da Vinci strategy assists surgeons successful performing minimally invasive procedures that trust connected tiny incisions and specialized tools to execute the desired results with minimal scars. It is cleared for urological, gynecological, and immoderate cardiac surgeries, among different uses.

One crushed Intuitive Surgical underperformed successful 2025 is that 1 of its peers successful the aesculapian instrumentality market, Medtronic, completed objective trials for a competing RAS system, the Hugo, successful urological procedures, and precocious earned clearance successful this indication. Medtronic volition question much approvals for its Hugo system, including successful hernia repairs.

Intuitive Surgical volition look tougher contention from present connected out. However, it is good equipped to grip it and inactive execute good implicit the agelong tally for 3 reasons.

First, it has a ample database of approved uses and a important installed base. Both are perpetually growing. In the 3rd quarter, the institution had an installed basal of 10,763 systems, representing a 13% year-over-year increase. And a fewer weeks ago, Intuitive Surgical announced regulatory support for 3 caller indications.